PubRank

Günter Burg

Author PubWeight™ 76.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 WHO-EORTC classification for cutaneous lymphomas. Blood 2005 12.14
2 Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005 4.04
3 Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004 1.96
4 Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 2011 1.85
5 Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol 2008 1.78
6 Dyscrasias with "undetermined significance". Arch Dermatol 2005 1.70
7 Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. Hum Pathol 2002 1.58
8 Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol 2010 1.55
9 Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002 1.54
10 Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst 2005 1.46
11 Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin. J Cutan Pathol 2005 1.40
12 Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 2004 1.16
13 Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther 2005 1.12
14 Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol 2002 1.07
15 Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003 1.06
16 Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood 2003 1.05
17 Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004 1.02
18 Dermatology online with interactive technology (DOIT). Curr Probl Dermatol 2003 1.00
19 Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology 2003 0.98
20 Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003 0.98
21 Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas. Blood 2004 0.96
22 Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood 2003 0.96
23 CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol 2005 0.95
24 High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma. J Immunother 2003 0.94
25 Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 2002 0.93
26 Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol 2004 0.91
27 Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol 2002 0.88
28 Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol 2002 0.88
29 Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology 2004 0.88
30 Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma 2006 0.87
31 Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate. Melanoma Res 2008 0.86
32 Serological immunomarkers in cutaneous T cell lymphoma. Dermatology 2004 0.86
33 Micronodular Kaposi's sarcoma - a new variant of classic-sporadic Kaposi's sarcoma. Dermatology 2004 0.86
34 Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol 2004 0.86
35 Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice. Exp Dermatol 2002 0.85
36 Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol 2003 0.85
37 Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 2003 0.83
38 Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers. Wound Repair Regen 2004 0.83
39 The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol 2002 0.82
40 Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. Blood 2003 0.82
41 Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha? Clin Cancer Res 2004 0.81
42 Expression of cancer/testis antigens in cutaneous T cell lymphomas. Int J Cancer 2002 0.81
43 Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Res 2004 0.81
44 Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol 2002 0.80
45 CO(2) laser surgery for extensive, cauliflower-like anogenital condylomata acuminata: retrospective long-term study on 19 HIV-positive and 45 HIV-negative men. Dermatology 2002 0.80
46 Recent advances in cutaneous lymphomas. J Dermatol Sci 2007 0.80
47 Mobile learning in resource-constrained environments: a case study of medical education. Med Teach 2012 0.79
48 High yields of autologous living dermal equivalents using porcine gelatin microbeads as microcarriers for autologous fibroblasts. Cell Transplant 2006 0.79
49 Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus. Recent Results Cancer Res 2002 0.78
50 Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol 2006 0.78
51 CO2 laser treatment of warts in immunosuppressed patients. Dermatology 2003 0.78
52 Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis 2003 0.78
53 Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol 2006 0.77
54 Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol 2002 0.77
55 A novel bioreactor microcarrier cell culture system for high yields of proliferating autologous human keratinocytes. Cell Transplant 2006 0.77
56 Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. J Cutan Pathol 2007 0.76
57 Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature. J Cutan Pathol 2002 0.76
58 Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. Cell Transplant 2004 0.76
59 Expression of melanoma-associated antigens in melanoma cell cultures. Exp Dermatol 2005 0.76
60 The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions. Am J Dermatopathol 2004 0.76
61 Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res 2003 0.76
62 Telemedicine in Europe. Curr Probl Dermatol 2003 0.76
63 Exploring primary cutaneous B-cell lymphoma by microarray technology. J Invest Dermatol 2003 0.75
64 Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol 2003 0.75
65 Bexarotene and systemic disease progression in CTCL? J Am Acad Dermatol 2006 0.75
66 Teledermatology in Switzerland. Curr Probl Dermatol 2003 0.75
67 A progressive papular eruption on the chest and back. Am J Dermatopathol 2004 0.75
68 [Eyebrow repair after skin cancer surgery: combined naked and hairbearing full thickness graft from the contralateral retroauricular donor site]. J Dtsch Dermatol Ges 2007 0.75
69 International board certification in dermatopathology: paving the way for the future. Am J Dermatopathol 2004 0.75
70 Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome. Int J Dermatol 2006 0.75
71 Clinical and therapeutic aspects of polymorphous light eruption. Dermatology 2003 0.75
72 [Perspective of cutaneous lymphoma reserach]. J Dtsch Dermatol Ges 2006 0.75
73 Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Exp Dermatol 2005 0.75
74 HistoClinC: a Web-based telemedicine application for clinicopathologic correlations in dermatopathology. Curr Probl Dermatol 2003 0.75
75 Painless erythema of the hands associated with non-Hodgkin's lymphoma in a lung transplant recipient. J Am Acad Dermatol 2002 0.75
76 [E-Learning in medicine: at the top or a flop]. J Dtsch Dermatol Ges 2008 0.75
77 Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation. Int J Dermatol 2007 0.75
78 'EASIdig'--a digital tool to document disease activity in atopic dermatitis. Dermatology 2011 0.75
79 Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures. Dermatology 2005 0.75
80 International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. J Cutan Pathol 2006 0.75
81 Weight of decision-making impairs clinical assessment of melanocytic lesions. J Cutan Med Surg 2007 0.75
82 International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. Am J Dermatopathol 2005 0.75
83 International Board certification dermatopathology: a worldwide effort to rise standards in dermatopathology. J Dtsch Dermatol Ges 2005 0.75
84 Teleteaching tools in dermatology on the Web. Curr Probl Dermatol 2003 0.75
85 Cutaneous lymphomas and pseudolymphomas: newly described entities. Recent Results Cancer Res 2002 0.75